At the time of this study initiation, the development of CAR T-cells in MM was expanding, following outstanding successes in B-cell malignancies and based on preliminary data obtained with CAR T-cells targeting the B-cell maturation antigen (BCMA). The gene discussed is TNFRSF17; the disease is Miyoshi myopathy.